Literature DB >> 18778360

Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status.

L-D Xie1, Y Gao, M-R Li, G-Z Lu, X-H Guo.   

Abstract

The mechanism of disease progression in Hashimoto's thyroiditis (HT) is still unclear. Anti-thyroid peroxidase antibody (TPOAb), a diagnostic hallmark of HT, is principally of the immunoglobulin G (IgG) isotype, and it appears to be a response to thyroid injury. The aim of our study was to evaluate the distribution of IgG subclasses of TPOAb in sera from patients with HT with different thyroid functional status. Sera from 168 patients with newly diagnosed HT were collected and divided into three groups according to thyroid function: patients with hypothyroidism (n = 66), subclinical hypothyroidism (n = 60) and euthyroidism (n = 42). Antigen-specific enzyme-linked immunosorbent assay was used to detect the distribution of TPOAb IgG subclasses. The prevalence of TPOAb IgG subclasses in all patients' sera with HT was IgG1 70.2%, IgG2 35.1%, IgG3 19.6% and IgG4 66.1% respectively. The prevalence of IgG2 in sera from patients with hypothyroidism (51.5%) was significantly higher than that of subclinical hypothyroidism (33.3%) (P < 0.05), and the latter was also significantly higher than that of euthyroidism (11.9%) (P < 0.05). The positive percentage of IgG2 subclass in sera from patients with hypothyroidism and subclinical hypothyroidism was significantly higher than that of euthyroidism (P < 0.05), the prevalence and positive percentage of IgG4 subclass in sera from patients with hypothyroidism and subclinical hypothyroidism was significantly higher than that of euthyroidism respectively (P < 0.05). The predominant TPOAb IgG subclasses in sera from patients with HT were IgG1 and IgG4. Patients with high levels of TPOAb IgG2, IgG4 subclasses might be at high risk of developing overt hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778360      PMCID: PMC2612718          DOI: 10.1111/j.1365-2249.2008.03756.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Restricted heterogeneity and T cell dependence of human thyroid autoantibody immunoglobulin G subclasses.

Authors:  T F Davies; C M Weber; P Wallack; M Platzer
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

Review 2.  IgG subclasses--a review.

Authors:  P H Schur
Journal:  Ann Allergy       Date:  1987-02

Review 3.  Immunoglobulin G: functional sites.

Authors:  D R Burton
Journal:  Mol Immunol       Date:  1985-03       Impact factor: 4.407

4.  The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses.

Authors:  A B Parkes; S M McLachlan; P Bird; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies.

Authors:  J Guo; J C Jaume; B Rapoport; S M McLachlan
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

6.  Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry.

Authors:  Russell Metcalfe; Nicola Jordan; Philip Watson; Sevim Gullu; Marie Wiltshire; Michele Crisp; Carol Evans; Anthony Weetman; Marian Ludgate
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).

Authors:  Costas Phenekos; Andromachi Vryonidou; Angelos D Gritzapis; Constantinos N Baxevanis; Margarita Goula; Michael Papamichail
Journal:  Neuroimmunomodulation       Date:  2004       Impact factor: 2.492

8.  IgG subclass distribution of thyroid autoantibodies: a 'fingerprint' of an individual's response to thyroglobulin and thyroid microsomal antigen.

Authors:  S M McLachlan; U Feldt-Rasmussen; E T Young; S L Middleton; M Dlichert-Toft; K Siersboek-Nielsen; J Date; D Carr; F Clark; B Rees Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1987-03       Impact factor: 3.478

9.  The T cell suppressor defect in autoimmune thyroiditis: evidence for a high set 'autoimmunostat'.

Authors:  T F Davies; M Platzer
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

10.  Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditis.

Authors:  Gherardo Mazziotti; Francesca Sorvillo; Caterina Naclerio; Angelo Farzati; Michele Cioffi; Rossella Perna; Gabriele Valentini; Bartolomeo Farzati; Giovanni Amato; Carlo Carella
Journal:  Eur J Endocrinol       Date:  2003-04       Impact factor: 6.664

View more
  7 in total

1.  Avidity of thyroglobulin antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status.

Authors:  Y Zhang; Y Gao; M Li; L Xie; Y Huang; Y Gao; X Guo
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

2.  [Value of ultrasound shear wave elasticity imaging in diagnosis of Hashimoto's thyroiditis].

Authors:  Wei Wang; Hai-Ning Zheng; Qiong Wang; Yi-Xiao Han; Qing-Gui Ye; Chao-Yang Wen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

3.  Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases.

Authors:  Michail Kaklamanos; Dimitrios Thomas; Dimitrios Pikazis; Gregory Kaltsas
Journal:  Endocrine       Date:  2015-02-18       Impact factor: 3.633

4.  Thyroid peroxidase autoantibodies are associated with a lesser likelihood of late reversion to hyperthyroidism after successful non-ablative treatment of Graves' disease in Croatian patients.

Authors:  M Stefanic; I Karner
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

5.  Serum levels of IgG and IgG4 in Hashimoto thyroiditis.

Authors:  Sachiko-Tsukamoto Kawashima; Tetsuya Tagami; Kanako Nakao; Kazutaka Nanba; Tamiko Tamanaha; Takeshi Usui; Mitsuhide Naruse; Sachiko Minamiguchi; Yusuke Mori; Jun Tsuji; Issei Tanaka; Akira Shimatsu
Journal:  Endocrine       Date:  2013-05-22       Impact factor: 3.633

Review 6.  Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.

Authors:  Eleonore Fröhlich; Richard Wahl
Journal:  Front Immunol       Date:  2017-05-09       Impact factor: 7.561

7.  Painful immunoglobulin G4-related thyroiditis treated by total thyroidectomy.

Authors:  Ihn Suk Lee; Jung Uee Lee; Kwan-Ju Lee; Yi Sun Jang; Jong Min Lee; Hye Soo Kim
Journal:  Korean J Intern Med       Date:  2016-02-26       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.